| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |